---
category: news
title: "One year in­to clin­i­cal hold, FDA has more ques­tions about 'pooled' mi­cro­bio­me ther­a­py"
excerpt: "The FDA is still wary about a trial testing a microbiome therapy in patients with steroid-resistant acute graft-versus-host disease (aGVHD). A year after MaaT Pharma’s IND application in the US was first met with a clinical hold,"
publishedDateTime: 2022-08-11T11:16:00Z
originalUrl: "https://endpts.com/one-year-into-clinical-hold-fda-has-more-questions-about-pooled-microbiome-therapy/"
webUrl: "https://endpts.com/one-year-into-clinical-hold-fda-has-more-questions-about-pooled-microbiome-therapy/"
type: article
quality: 0
heat: 0
published: false

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - Computer Vision
  - AI

secured: "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;/SYnpeGa9bFfVSp+mYGMxQ=="
---

